Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

AN2 Therapeutics, Inc.

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-21Dec-31-20
   S-1/AS-1/A
Assets  
Cash and equivalents  12.14.1
Short-term investments  46.5 
Other current assets  1.60.2
Total current assets  60.14.2
Long-term investments  3.5 
Total assets  65.34.2
   
Accounts payable  1.10.1
Accrued expenses   0.9
Short-term debt  0.00.0
Other current liabilities  2.30.4
Total current liabilities  3.41.5
Other liabilities  0.00.0
Total liabilities  3.41.5
   
Shareholders' equity   [+]61.92.8
Tangible shareholders' equity  61.92.8

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy